Skip to content
Clinical Trials – home
Rare disease

Precursor B-lymphoblastic lymphoma refractory

  • 3 clinical trials
Quick filters

3 Clinical trials

Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years
  • Substances:Ruxolitinib
  • Sponsor:Princess Maxima Center For Pediatric Oncology
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years
  • Substances:Trametinib
  • Sponsor:Princess Maxima Center For Pediatric Oncology
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years
  • Substances:Dasatinib
  • Sponsor:Princess Maxima Center For Pediatric Oncology
See all trials →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.